Today we speak with Frenk Smrekar, the Founder and CEO of JAFRAL and the Vice-President of PhageEU, he has been working in the field of bacteriophage production since he started his PhD in 2005.

On this episode we cover his work in Jafral and much more: he gives his thoughts and experience on phage production, manufacturing and GMP production; on whether we need GMP for phage therapy and we also cover the mission of PhageEU (https://phageurope.eu)

We also did not miss the chance to ask him about the transition from academia to industry.

A must listen for anyone interested in the field of phage therapy!

Enjoy!

Episode chapters:

What is Jafral doing?

What is GMP production?

In which case would it make sense to have phage produced under GMP?

What is the real cost of GMP?

What about phage cocktails?

What do you look for in production strains?

What about endotoxins?

How do you purify phages?

Should labs be purifying the phages before running their tests?

What is phage EU?

How did you get introduced to the world of phages?

What were the challenges in your entrepreneurial journey?

What skills do you look for in industry in people after their PhDs?

Would you have any advice for someone looking into entrepreneurship?

What are you most excited about the future of the field?